Cargando…
Dyslipidemia and Diabetes Increase the OPG/TRAIL Ratio in the Cardiovascular System
Background. Dyslipidemia and diabetes are two of the most well established risk factors for the development of cardiovascular disease (CVD). Both of them usually activate a complex range of pathogenic pathways leading to organ damage. Here we hypothesized that dyslipidemia and diabetes could affect...
Autores principales: | Toffoli, Barbara, Fabris, Bruno, Bartelloni, Giacomo, Bossi, Fleur, Bernardi, Stella |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5192341/ https://www.ncbi.nlm.nih.gov/pubmed/28070143 http://dx.doi.org/10.1155/2016/6529728 |
Ejemplares similares
-
Roles and Clinical Applications of OPG and TRAIL as Biomarkers in Cardiovascular Disease
por: Bernardi, Stella, et al.
Publicado: (2016) -
TRAIL Modulates the Immune System and Protects against the Development of Diabetes
por: Bossi, Fleur, et al.
Publicado: (2015) -
TRAIL, OPG, and TWEAK in kidney disease: biomarkers or therapeutic targets?
por: Bernardi, Stella, et al.
Publicado: (2019) -
TRAIL/DR5 pathway promotes AKT phosphorylation, skeletal muscle differentiation, and glucose uptake
por: Toffoli, Barbara, et al.
Publicado: (2021) -
Circulating osteoprotegerin is associated with chronic kidney disease in hypertensive patients
por: Bernardi, Stella, et al.
Publicado: (2017)